ENV-308 Exercise-Mimicking Weight-Loss Pill Clears Phase 1 Trials
Boulder biotech Enveda announced in August 2026 that its experimental oral drug ENV-308, designed to mimic the exercise-induced hormone Lac-Phe, successfully cleared a Phase 1 clinical … Read more